- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02951455
Community Wise: An Innovative Multi-level Intervention to Reduce Alcohol and Illegal Drug Use
Study Overview
Status
Conditions
Detailed Description
The current project seeks to implement the Multiphase Optimization Strategy (MOST) and Community Based Participatory Research (CBPR) principles to identify the most efficient, scalable, and sustainable combination of Community Wise components. Community Wise is a manualized multi-level intervention aimed at reducing health inequalities related to alcohol and illicit drug use (AIDU). The research will be conducted by the Newark Community Collaborative Board (NCCB), a network that developed and pilot-tested the original Community Wise. NCCB members include the principal investigators (PIs), co-investigators (Co-Is), service providers, consumers of AIDU, and community members.
Specific aims include:
Aim 1: Use a highly efficient experimental design to estimate the unique contribution of key components of Community Wise in: a) reducing AIDU frequency and b) increasing the percentage of participants abstinent over five months. Components tested are the presence or absence of: (a) Critical Dialogue; (b) Quality-of-Life-Wheel; (c) Capacity Building Project; and (d) group facilitation by a peer versus a licensed clinician. A factorial experiment will be used to detect effects of individual components and three-way interactions.
Aim 2: Informed by MOST, Community Wise will be optimized for scalability and sustainability-- the most efficacious combination of components that can be delivered for less than $2000 per intervention cycle serving up to eleven individuals simultaneously (as per recommendations by the Substance Abuse and Mental Health Services Administration (SAMHSA).
This 2x2x2x2 factorial design will be fully powered to detect change in AIDU in a sample of 528 men with substance use disorders and a history of incarceration residing in distressed communities with predominantly Black populations. Participants will be randomly assigned to one of sixteen experimental conditions. The first eight conditions will be facilitated by a licensed facilitator. The remaining conditions will be facilitated by a peer facilitator. Each set of eight conditions will include the following components: (1) Critical Dialogue (CD) only; (2) Quality-of-Life-Wheel (QLW) only; (3) Capacity Building Project (CBP) only; (4) CD+QLW; (5) CD+CBP; (6) QLW+CBP; (7) CD+QLW+CBP; and (8) no components. Data will be collected at baseline plus five post-baseline monthly follow-ups. This study has potential to impact public health; the use of CBPR and MOST will generate action-oriented implications and an optimized multi-level intervention adaptable to address different health inequalities.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New Jersey
-
Newark, New Jersey, United States, 07102
- Integrity House
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Inclusion criteria for the factorial experiment participants in the study will include:
- Men age 18 or older
- Residence in Essex County, NJ
- Willingness to be voice recorded during group sessions
- Ability to speak English
- Having a substance use disorder measured by the Global Appraisal of Individual Needs-Substance Problem Scale (GAIN-SPS).
- Having been released from incarceration in the past 4 years. This is due to research that shows that people are more likely to be re-incarcerated within the first 4 years of release from incarceration.
Exclusion Criteria:
- Severe psychiatric disorders in the prior 6 months not stabilized (schizophrenia, depression with psychotic features, bipolar disorder, any psychosis), as measured by the MINI International Neuropsychiatric Interview 6 psychoticism and suicidality modules
- Gross cognitive impairment as measured by the Mini Mental State Exam.
- Sexual identification as female
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CD-LC
Group behavioral intervention with 9 weekly sessions lasting 2 hours.
Critical Dialogue (CD), Licensed Clinician (LC).
|
Prompted by thematic images, aims to help participants develop a deeper understanding of how marginalizing processes (e.g., systematic stigma; feelings of rage as victims of discrimination) impact participants' lives and behavior.
Other Names:
Whether the intervention is delivered by a licensed clinician.
|
Experimental: CBP- LC
Group community mobilizing intervention with 9 weekly sessions spread in 15 weeks.
Capacity Building Project (CBP), Licensed Clinician (LC)
|
Whether the intervention is delivered by a licensed clinician.
Designed to create collaborative efforts to overcome and dismantle marginalizing processes by building positive social and organizational relationships and community capacity through the development and implementation of community projects aiming to address social determinants of health.
Other Names:
|
Experimental: QLW- LC
Group intervention where participants learn to develop and implement personal goals that are measurable, attainable, realistic, and time bound.
Intervention includes 9 sessions.
Quality of Life Wheel, Licensed Clinician (LC)
|
Whether the intervention is delivered by a licensed clinician.
Aims to increase self-efficacy and help participants develop a vision for their future, breaking this vision down into small, feasible, measureable goals they can implement on a weekly basis (e.g.
quitting smoking, improving relationships with family members, paying down debt).
Other Names:
|
Experimental: CD & CBP- LC
Combination of group behavioral intervention and community mobilization intervention including 15 weekly sessions.Licensed Clinician (LC)
|
Prompted by thematic images, aims to help participants develop a deeper understanding of how marginalizing processes (e.g., systematic stigma; feelings of rage as victims of discrimination) impact participants' lives and behavior.
Other Names:
Whether the intervention is delivered by a licensed clinician.
Designed to create collaborative efforts to overcome and dismantle marginalizing processes by building positive social and organizational relationships and community capacity through the development and implementation of community projects aiming to address social determinants of health.
Other Names:
|
Experimental: CD & QLW- LC
Combination of group behavioral intervention and community mobilization intervention including 15 weekly sessions.Licensed Clinician (LC)
|
Prompted by thematic images, aims to help participants develop a deeper understanding of how marginalizing processes (e.g., systematic stigma; feelings of rage as victims of discrimination) impact participants' lives and behavior.
Other Names:
Whether the intervention is delivered by a licensed clinician.
Aims to increase self-efficacy and help participants develop a vision for their future, breaking this vision down into small, feasible, measureable goals they can implement on a weekly basis (e.g.
quitting smoking, improving relationships with family members, paying down debt).
Other Names:
|
Experimental: QLW & Capacity Building ProjectCBP- LC
Combination of goal development and implementation with community mobilization intervention including 9 weekly sessions spread across 15 weeks.
Licensed Clinician (LC)
|
Whether the intervention is delivered by a licensed clinician.
Designed to create collaborative efforts to overcome and dismantle marginalizing processes by building positive social and organizational relationships and community capacity through the development and implementation of community projects aiming to address social determinants of health.
Other Names:
Aims to increase self-efficacy and help participants develop a vision for their future, breaking this vision down into small, feasible, measureable goals they can implement on a weekly basis (e.g.
quitting smoking, improving relationships with family members, paying down debt).
Other Names:
|
Experimental: QLW & CD & CBP-LC
Combination of group behavioral intervention, goal development and implementation, and community mobilization intervention including 15 weekly sessions.Licensed Clinician (LC)
|
Prompted by thematic images, aims to help participants develop a deeper understanding of how marginalizing processes (e.g., systematic stigma; feelings of rage as victims of discrimination) impact participants' lives and behavior.
Other Names:
Whether the intervention is delivered by a licensed clinician.
Designed to create collaborative efforts to overcome and dismantle marginalizing processes by building positive social and organizational relationships and community capacity through the development and implementation of community projects aiming to address social determinants of health.
Other Names:
Aims to increase self-efficacy and help participants develop a vision for their future, breaking this vision down into small, feasible, measureable goals they can implement on a weekly basis (e.g.
quitting smoking, improving relationships with family members, paying down debt).
Other Names:
|
Experimental: LC
This condition will include 3 core sessions that are not a part of the components being tested.
These are support sessions to the components being tested and is hypothesized to have the smallest impact on substance use outcomes.Licensed Clinician (LC)
|
Whether the intervention is delivered by a licensed clinician.
|
Experimental: CD- PF
Group behavioral intervention with 9 weekly sessions lasting 2 hours.
Critical Dialogue (CD), Peer Facilitator (PF)
|
Prompted by thematic images, aims to help participants develop a deeper understanding of how marginalizing processes (e.g., systematic stigma; feelings of rage as victims of discrimination) impact participants' lives and behavior.
Other Names:
Whether the intervention is delivered by a peer facilitator.
|
Experimental: CBP- PF
Group community mobilizing intervention with 9 weekly sessions spread in 15 weeks.
Capacity Building Project (CBP), Peer Facilitator (PF)
|
Designed to create collaborative efforts to overcome and dismantle marginalizing processes by building positive social and organizational relationships and community capacity through the development and implementation of community projects aiming to address social determinants of health.
Other Names:
Whether the intervention is delivered by a peer facilitator.
|
Experimental: QLW-PF
Group intervention where participants learn to develop and implement personal goals that are measurable, attainable, realistic, and time bound.
Intervention includes 9 sessions.
Quality of Life wheel, Peer Facilitator (PF)
|
Aims to increase self-efficacy and help participants develop a vision for their future, breaking this vision down into small, feasible, measureable goals they can implement on a weekly basis (e.g.
quitting smoking, improving relationships with family members, paying down debt).
Other Names:
Whether the intervention is delivered by a peer facilitator.
|
Experimental: CD & CBP- PF
Combination of group behavioral intervention and community mobilization intervention including 15 weekly sessions.
Peer Facilitator (PF)
|
Prompted by thematic images, aims to help participants develop a deeper understanding of how marginalizing processes (e.g., systematic stigma; feelings of rage as victims of discrimination) impact participants' lives and behavior.
Other Names:
Designed to create collaborative efforts to overcome and dismantle marginalizing processes by building positive social and organizational relationships and community capacity through the development and implementation of community projects aiming to address social determinants of health.
Other Names:
Whether the intervention is delivered by a peer facilitator.
|
Experimental: CD & QLW- PF
Combination of group behavioral intervention and community mobilization intervention including 15 weekly sessions.Peer Facilitator (PF)
|
Prompted by thematic images, aims to help participants develop a deeper understanding of how marginalizing processes (e.g., systematic stigma; feelings of rage as victims of discrimination) impact participants' lives and behavior.
Other Names:
Aims to increase self-efficacy and help participants develop a vision for their future, breaking this vision down into small, feasible, measureable goals they can implement on a weekly basis (e.g.
quitting smoking, improving relationships with family members, paying down debt).
Other Names:
Whether the intervention is delivered by a peer facilitator.
|
Experimental: QLW & CBP- PF
Combination of goal development and implementation with community mobilization intervention including 9 weekly sessions spread across 15 weeks.Peer Facilitator (PF)
|
Designed to create collaborative efforts to overcome and dismantle marginalizing processes by building positive social and organizational relationships and community capacity through the development and implementation of community projects aiming to address social determinants of health.
Other Names:
Aims to increase self-efficacy and help participants develop a vision for their future, breaking this vision down into small, feasible, measureable goals they can implement on a weekly basis (e.g.
quitting smoking, improving relationships with family members, paying down debt).
Other Names:
Whether the intervention is delivered by a peer facilitator.
|
Experimental: CD & QLW & CBP- PF
Combination of group behavioral intervention, goal development and implementation, and community mobilization intervention including 15 weekly sessions.Peer Facilitator (PF)
|
Prompted by thematic images, aims to help participants develop a deeper understanding of how marginalizing processes (e.g., systematic stigma; feelings of rage as victims of discrimination) impact participants' lives and behavior.
Other Names:
Designed to create collaborative efforts to overcome and dismantle marginalizing processes by building positive social and organizational relationships and community capacity through the development and implementation of community projects aiming to address social determinants of health.
Other Names:
Aims to increase self-efficacy and help participants develop a vision for their future, breaking this vision down into small, feasible, measureable goals they can implement on a weekly basis (e.g.
quitting smoking, improving relationships with family members, paying down debt).
Other Names:
Whether the intervention is delivered by a peer facilitator.
|
Experimental: PF
This condition will include 3 core sessions that are not a part of the components being tested.
These are support sessions to the components being tested and is hypothesized to have the smallest impact on substance use outcomes.
Peer Facilitator (PF)
|
Whether the intervention is delivered by a peer facilitator.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of Days of Alcohol or Substance Misuse in the Past 30 Days
Time Frame: 5 months
|
The primary outcome was the percentage of ASM (i.e., the percentage of days each substance was used in the past month) as operationalized by the Global Assessment of Individual needs.
At each time point (baseline, five follow-ups), percentage ASM was calculated by dividing the reported number of days in the past month that participants used cannabis, heroin, alcohol, opioids, or cocaine by the number of days in the month (data were collected with the Timeline Follow-Back measure), multiplied by 100.
Next, mean ASM frequency per month during 5 months of follow-up was calculated by adding the percentages for each substance and dividing by 5.31 We conducted correlations for self-reported ASM in the past 30 days with toxicology urine screens to assess validity of self-reported data.
|
5 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of People Abstinent From Alcohol and Drug Use
Time Frame: 5 months
|
Number of people abstinent from alcohol and drug use, which is assessed via the timeline follow back scale
|
5 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Liliane Windsor, PhD, University of Illinois Urbana-Champaign
Publications and helpful links
General Publications
- Windsor LC, Benoit E, Pinto RM, Gwadz M, Thompson W. Enhancing behavioral intervention science: using community-based participatory research principles with the multiphase optimization strategy. Transl Behav Med. 2021 Aug 13;11(8):1596-1605. doi: 10.1093/tbm/ibab032.
- Windsor LC, Benoit E, Smith D, Pinto RM, Kugler KC; Newark Community Collaborative Board (NCCB). Optimizing a community-engaged multi-level group intervention to reduce substance use: an application of the multiphase optimization strategy. Trials. 2018 Apr 27;19(1):255. doi: 10.1186/s13063-018-2624-5.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1U01MD010629-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Investigators will require a data- sharing agreement that provides for the following conditions at minimum: (1) a commitment to using the data only for research purposes and not to identify any individual participant; (2) a commitment to securing the data using appropriate tools and computer technology; and (3) a commitment to destroying or returning the data after analyses are completed.
All data will be stripped of personal identifiers so as to be suitable for use by other investigators. Even though the database will be stripped of identifiers prior to any sharing, however, we will make the data and associated documentation available to users only under a data-sharing agreement that provides for the above-stated commitments.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Use Disorders
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Substance Use Disorders | Cannabis Use | Alcohol Use, UnspecifiedUnited States
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use Disorder | Cocaine Use DisorderUnited States
-
Woebot HealthNational Institute on Drug Abuse (NIDA); Stanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
University of MichiganNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingSubstance Use | Substance Use Disorders | Substance DependenceUnited States
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNYCompletedSubstance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance WithdrawalUnited States
-
Wake Forest University Health SciencesNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Opioid Use | Drug Use | Substance MisuseUnited States
-
Centre for Addiction and Mental HealthUniversity of Missouri, St. LouisCompletedSubstance Use Disorders | Alcohol Use DisorderCanada
-
Istanbul UniversityCompletedSubstance Use | Substance Use Disorders | Substance AbuseTurkey
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)CompletedPTSD | Alcohol Use Disorders | Substance Use DisordersUnited States
Clinical Trials on Critical Dialogue
-
University of Illinois at Urbana-ChampaignNational Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaboratorsCompleted
-
University of Illinois at Urbana-ChampaignNational Institute on Minority Health and Health Disparities (NIMHD); University... and other collaboratorsCompletedCOVID-19 TestingUnited States
-
The University of Texas Health Science Center at...CompletedHand DisinfectionUnited States
-
Sahlgrenska University Hospital, SwedenRecruitingConstriction, Pathologic | Surgery | Radiculopathy | Spine DegenerationSweden
-
Nicolas DEMARTINESCompletedPostoperative Complications | Anxiety | Satisfaction, Patient | Post Operative Pain | Postoperative NauseaSwitzerland
-
Yale UniversityInnovations for Poverty Action; International Rescue CommitteeCompletedDomestic Violence | Family and HouseholdCôte D'Ivoire
-
University Hospital FreiburgCompletedDepression | Acute Low Back PainGermany
-
Danish Labor InspectorateNational Research Centre for the Working Environment, DenmarkRecruitingOccupational Diseases | Safety Issues | Occupational InjuriesDenmark
-
University of PittsburghUniversity of PennsylvaniaCompletedRisk ReductionUnited States